13 June 2024
Mursla Bio launches US strategy to bring its novel liquid biopsy tests – based on extracellular vesicle technology – to patients
3 June 2024
Novel and scalable analysis of extracellular vesicles sub-types detailed in Cell Press’ iScience
4 October 2023
Mursla Bio participates in a unique global initiative to standardise the clinical use of novel EV-based biomarkers for liquid biopsy
1 June 2023
Mursla Bio was selected to present at the largest pharmaceutical and biotech partnering event
22 May 2023
Showcase spotlights Mursla Bio's first-in-class science and upcoming milestones for flagship product launch
